Suppr超能文献

miR-203 通过下调 Akt2 表达逆转 p53 突变型结肠癌细胞的化疗耐药性。

miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression.

机构信息

Hepatobiliary & Enteric Surgery Research Center, Central South University, Changsha 410008, China.

出版信息

Cancer Lett. 2011 May 1;304(1):52-9. doi: 10.1016/j.canlet.2011.02.003. Epub 2011 Feb 26.

Abstract

In this study, we explored miR-203's role in the chemoresistance of colon cancer. We found that overexpression of miR-203 significantly decreased cell proliferation and survival, and induced cell apoptosis in the p53-mutated colon cancer cells. Importantly, miR-203 overexpression increased the cytotoxic role of paclitaxel in the p53-mutated colon cancer cells, but not in the p53 wild-type cells. We further demonstrated that the tumor suppressive role of miR-203 was mediated by negatively regulating Akt2 protein expression through mRNA degradation. The inhibition of Akt2 activity downregulated the protein expression of its downstream molecules involved in chemoresistance, such as MTDH and HSP90 genes. Also, overexpression of miR-203 decreased anti-apoptotic gene Bcl-xL expression and increased apoptotic proteins Bax and active caspase-3 levels. Our study is the first to identify the tumor suppressive role of overexpressed miR-203, describe its associated signaling pathways, and highlight the role of miR-203 in chemoresistance.

摘要

在这项研究中,我们探讨了 miR-203 在结肠癌化疗耐药中的作用。我们发现,miR-203 的过表达显著降低了 p53 突变型结肠癌细胞的增殖和存活,并诱导了细胞凋亡。重要的是,miR-203 的过表达增加了紫杉醇对 p53 突变型结肠癌细胞的细胞毒性作用,但对 p53 野生型细胞没有作用。我们进一步证明,miR-203 的肿瘤抑制作用是通过 mRNA 降解负调控 Akt2 蛋白表达来介导的。Akt2 活性的抑制下调了其下游参与化疗耐药的分子的蛋白表达,如 MTDH 和 HSP90 基因。此外,miR-203 的过表达降低了抗凋亡基因 Bcl-xL 的表达,并增加了凋亡蛋白 Bax 和活性 caspase-3 的水平。我们的研究首次鉴定了过表达的 miR-203 的肿瘤抑制作用,描述了其相关的信号通路,并强调了 miR-203 在化疗耐药中的作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验